*ST Jiyou announced that the company plans to acquire more than 50% of Jiangsu Huiju Pharmaceutical's shares in cash and obtain control, which is expected to constitute a major asset restructuring and related transaction. On June 18, 2026, the company and shareholders of the target company signed the “Stock Acquisition Intent Agreement”. As of the date of disclosure of the announcement, the company is promoting due diligence, audit, evaluation, etc., and communicating and negotiating with relevant parties. The parties involved in the transaction have not yet signed a formal agreement, and there is uncertainty about whether it can be implemented and the progress.

*ST Jiyou announced that the company plans to acquire more than 50% of Jiangsu Huiju Pharmaceutical's shares in cash and obtain control, which is expected to constitute a major asset restructuring and related transaction. On June 18, 2026, the company and shareholders of the target company signed the “Stock Acquisition Intent Agreement”. As of the date of disclosure of the announcement, the company is promoting due diligence, audit, evaluation, etc., and communicating and negotiating with relevant parties. The parties involved in the transaction have not yet signed a formal agreement, and there is uncertainty about whether it can be implemented and the progress.